Showing results (421-430 of 535) with videos related to

Sort By:
Pageof 54
The Lancet. Neurology|August 1, 2015
Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based studyLinxin Li, Gabriel S Yiin, Olivia C Geraghty, et al.
Acta Diabetologica|June 5, 2002
The influence of local capsaicin treatment on small nerve fibre function and neurovascular control in symptomatic diabetic neuropathyT Forst, T Pohlmann, T Kunt, et al.
Medical and Pediatric Oncology. Supplement|January 1, 1992
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell countsP Valent, C Sillaber, K Geissler, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1995
[Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI]U Büll, Y Foroutan, D Hellwig, et al.
Nuklearmedizin. Nuclear Medicine|May 7, 2002
[Multivariate analysis of factors influencing the effect of radiosynovectomy]J Farahati, G Schulz, J Wendler, et al.
Nature|August 6, 2004
Effect of trace metal availability on coccolithophorid calcificationK G Schulz, I Zondervan, L J A Gerringa, et al.
Surgical Neurology|July 2, 1999
Preoperative PET activation for assessment of motor cortex area in precentral chondromaM Schreckenberger, U Spetzger, O Sabri, et al.
Occupational and Environmental Medicine|June 16, 2000
Health complaints and immunological markers of exposure to bioaerosols among biowaste collectors and compost workersJ Bünger, M Antlauf-Lammers, T G Schulz, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Immunotherapy of pancreatic cancer with monoclonal antibody BW 494G Schulz, M Büchler, K H Muhrer, et al.
Blood|January 1, 1990
Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphomaA D Ho, R Haas, G Wulf, et al.
Pageof 54